![[ICO]](/icons/blank.gif) | Name | Last modified | Size | Description |
|
![[PARENTDIR]](/icons/back.gif) | Parent Directory | | - | |
![[ ]](/icons/layout.gif) | USJ.pdf | 2024-10-09 07:49 | 1.0M | |
![[ ]](/icons/layout.gif) | Patient Profile MTM - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 2.3M | |
![[ ]](/icons/layout.gif) | OPLSoftSkillsCEProgram2017.pdf | 2024-10-09 07:49 | 166K | |
![[ ]](/icons/layout.gif) | OPLSoftSkillsCEProgram2017-.pdf | 2024-10-09 07:49 | 109K | |
![[ ]](/icons/layout.gif) | OPLPatientProfileCEProgram2017.pdf | 2024-10-09 07:49 | 99K | |
![[ ]](/icons/layout.gif) | OPL CE Program - Calendar 2015.pdf | 2024-10-09 07:49 | 6.5M | |
![[ ]](/icons/layout.gif) | Mental Disorders - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 903K | |
![[ ]](/icons/layout.gif) | Medication Safety - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 1.0M | |
![[ ]](/icons/layout.gif) | Hyperlipidemia and Hypertension - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 1.8M | |
![[ ]](/icons/layout.gif) | Diabetes - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 1.4M | |
![[ ]](/icons/layout.gif) | Cardiovascular Diseases 2 - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 957K | |
![[ ]](/icons/layout.gif) | Cardiovascular Diseases 1 - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 1.4M | |
![[ ]](/icons/layout.gif) | BAU.pdf | 2024-10-09 07:49 | 149K | |
![[ ]](/icons/layout.gif) | Asthma and COPD - OPL PP CE 2017.pdf | 2024-10-09 07:49 | 1.5M | |
|